KRISTI ERNANDEZ: Open Payments
NPI 1679045017 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 94 payments from 11 companies in 2025. Trend: 2023 $1,191 · 2024 $1,697 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $218 |
| Teva Pharmaceuticals USA, Inc. | 7 | $207 |
| Neurocrine BioSciences, Inc. | 16 | $203 |
| E.R. Squibb & Sons, L.L.C. | 14 | $199 |
| ABBVIE INC. | 16 | $170 |
| Alkermes, Inc. | 8 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 5 | $79 |
| Janssen Pharmaceuticals, Inc | 4 | $74 |
| Lundbeck LLC | 1 | $19 |
Products named: INGREZZA, COBENFY, VRAYLAR, UZEDY, REXULTI, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA.
Industry payments across SC — which companies pay providers there.
